Announcement of Sansure Biotech Inc. on the Change of Registered Capital, Revision of Articles of Association and Business Registration
Announcement of Sansure Biotech Inc.'s reply to the regulatory inquiry letter regarding the disclosure of information in the 2023 annual report.
Announcement of Sansure Biotech Inc.'s voluntary disclosure of obtaining medical instrument registration certificate for related products.
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Shengxiang Biotechnology Co., Ltd.
Legal Opinion of Hunan Qiyuan Law Firm on the 2023 Annual General Meeting of Shareholders of Shengxiang Biotechnology Co., Ltd.
Announcement of Shengxiang Biotechnology Co., Ltd. on canceling part of the repurchased shares and reducing registered capital and notifying creditors
Shengxiang Biotechnology Co., Ltd. 2023 Annual General Meeting of Shareholders Meeting Materials
Announcement of Shengxiang Biotechnology Co., Ltd. on joint investment and transfer of shares in participating companies with related parties
Notice of Shengxiang Biotechnology Co., Ltd. on convening the 2023 Annual General Meeting of Shareholders
Shengxiang Biotechnology Co., Ltd. Audit Committee's 2023 Performance Report
Special report of the board of directors of Shengxiang Biotechnology Co., Ltd. on the self-inspection of the independence of independent directors
Shengxiang Biotechnology Co., Ltd. 2024 “Improve Quality, Increase Efficiency, and Value Rewards” Action Plan
Announcement of Shengxiang Biotechnology Co., Ltd. on the appointment of the company's 2024 financial auditing agency and internal control auditor
Announcement of Shengxiang Biotechnology Co., Ltd. on revising the “Articles of Association” and some governance systems
Rules of procedure for the board of directors of Shengxiang Biotechnology Co., Ltd.
Announcement of Shengxiang Biotechnology Co., Ltd. on changing the use of some repurchased shares, cancellation, and reduction of registered capital
Shengxiang Biotechnology Co., Ltd. 2023 Internal Control Evaluation Report
Announcement of Shengxiang Biotechnology Co., Ltd. on the annulled portion of restricted shares granted that have not yet been vested
Announcement of Shengxiang Biotechnology Co., Ltd. on the change of board secretary and securities affairs representative
Announcement of Shengxiang Biotechnology Co., Ltd. on voluntary disclosure of related products to obtain medical device registration certificates
No Data